List of Chapters/Sections(Table Of Content)
1 Pharmaceutical Intermediates Market Overview
1.1 Product Overview and Scope of Pharmaceutical Intermediates
1.2 Pharmaceutical Intermediates Segment by Type
1.2.1 Global Pharmaceutical Intermediates Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 GMP
1.2.3 Non-GMP
1.3 Pharmaceutical Intermediates Segment by Application
1.3.1 Global Pharmaceutical Intermediates Sales Comparison by Application: (2021-2027)
1.3.2 Antibiotics
1.3.3 Antipyretic Analgesics
1.3.4 Vitamins
1.3.5 Others
1.4 Global Pharmaceutical Intermediates Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Intermediates Revenue 2016-2027
1.4.2 Global Pharmaceutical Intermediates Sales 2016-2027
1.4.3 Pharmaceutical Intermediates Market Size by Region: 2016 Versus 2021 Versus 2027
2 Pharmaceutical Intermediates Market Competition by Manufacturers
2.1 Global Pharmaceutical Intermediates Sales Market Share by Manufacturers (2016-2021)
2.2 Global Pharmaceutical Intermediates Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pharmaceutical Intermediates Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pharmaceutical Intermediates Manufacturing Sites, Area Served, Product Type
2.5 Pharmaceutical Intermediates Market Competitive Situation and Trends
2.5.1 Pharmaceutical Intermediates Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pharmaceutical Intermediates Players Market Share by Revenue
2.5.3 Global Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pharmaceutical Intermediates Retrospective Market Scenario by Region
3.1 Global Pharmaceutical Intermediates Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Pharmaceutical Intermediates Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Pharmaceutical Intermediates Market Facts & Figures by Country
3.3.1 North America Pharmaceutical Intermediates Sales by Country
3.3.2 North America Pharmaceutical Intermediates Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pharmaceutical Intermediates Market Facts & Figures by Country
3.4.1 Europe Pharmaceutical Intermediates Sales by Country
3.4.2 Europe Pharmaceutical Intermediates Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pharmaceutical Intermediates Market Facts & Figures by Region
3.5.1 Asia Pacific Pharmaceutical Intermediates Sales by Region
3.5.2 Asia Pacific Pharmaceutical Intermediates Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Pharmaceutical Intermediates Market Facts & Figures by Country
3.6.1 Latin America Pharmaceutical Intermediates Sales by Country
3.6.2 Latin America Pharmaceutical Intermediates Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pharmaceutical Intermediates Market Facts & Figures by Country
3.7.1 Middle East and Africa Pharmaceutical Intermediates Sales by Country
3.7.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Pharmaceutical Intermediates Historic Market Analysis by Type
4.1 Global Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
4.2 Global Pharmaceutical Intermediates Revenue Market Share by Type (2016-2021)
4.3 Global Pharmaceutical Intermediates Price by Type (2016-2021)
5 Global Pharmaceutical Intermediates Historic Market Analysis by Application
5.1 Global Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
5.2 Global Pharmaceutical Intermediates Revenue Market Share by Application (2016-2021)
5.3 Global Pharmaceutical Intermediates Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Lonza
6.1.1 Lonza Corporation Information
6.1.2 Lonza Description and Business Overview
6.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Lonza Pharmaceutical Intermediates Product Portfolio
6.1.5 Lonza Recent Developments/Updates
6.2 Catalent
6.2.1 Catalent Corporation Information
6.2.2 Catalent Description and Business Overview
6.2.3 Catalent Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Catalent Pharmaceutical Intermediates Product Portfolio
6.2.5 Catalent Recent Developments/Updates
6.3 Patheon
6.3.1 Patheon Corporation Information
6.3.2 Patheon Description and Business Overview
6.3.3 Patheon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Patheon Pharmaceutical Intermediates Product Portfolio
6.3.5 Patheon Recent Developments/Updates
6.4 Jubilant
6.4.1 Jubilant Corporation Information
6.4.2 Jubilant Description and Business Overview
6.4.3 Jubilant Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Jubilant Pharmaceutical Intermediates Product Portfolio
6.4.5 Jubilant Recent Developments/Updates
6.5 Granules
6.5.1 Granules Corporation Information
6.5.2 Granules Description and Business Overview
6.5.3 Granules Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Granules Pharmaceutical Intermediates Product Portfolio
6.5.5 Granules Recent Developments/Updates
6.6 Ganesh
6.6.1 Ganesh Corporation Information
6.6.2 Ganesh Description and Business Overview
6.6.3 Ganesh Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Ganesh Pharmaceutical Intermediates Product Portfolio
6.6.5 Ganesh Recent Developments/Updates
6.7 Chemcon
6.6.1 Chemcon Corporation Information
6.6.2 Chemcon Description and Business Overview
6.6.3 Chemcon Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Chemcon Pharmaceutical Intermediates Product Portfolio
6.7.5 Chemcon Recent Developments/Updates
6.8 BASF
6.8.1 BASF Corporation Information
6.8.2 BASF Description and Business Overview
6.8.3 BASF Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.8.4 BASF Pharmaceutical Intermediates Product Portfolio
6.8.5 BASF Recent Developments/Updates
6.9 Porton
6.9.1 Porton Corporation Information
6.9.2 Porton Description and Business Overview
6.9.3 Porton Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Porton Pharmaceutical Intermediates Product Portfolio
6.9.5 Porton Recent Developments/Updates
6.10 Lianhetech
6.10.1 Lianhetech Corporation Information
6.10.2 Lianhetech Description and Business Overview
6.10.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Lianhetech Pharmaceutical Intermediates Product Portfolio
6.10.5 Lianhetech Recent Developments/Updates
6.11 ABA Chem
6.11.1 ABA Chem Corporation Information
6.11.2 ABA Chem Pharmaceutical Intermediates Description and Business Overview
6.11.3 ABA Chem Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.11.4 ABA Chem Pharmaceutical Intermediates Product Portfolio
6.11.5 ABA Chem Recent Developments/Updates
6.12 Tianma
6.12.1 Tianma Corporation Information
6.12.2 Tianma Pharmaceutical Intermediates Description and Business Overview
6.12.3 Tianma Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Tianma Pharmaceutical Intermediates Product Portfolio
6.12.5 Tianma Recent Developments/Updates
6.13 Jiujiujiu
6.13.1 Jiujiujiu Corporation Information
6.13.2 Jiujiujiu Pharmaceutical Intermediates Description and Business Overview
6.13.3 Jiujiujiu Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Jiujiujiu Pharmaceutical Intermediates Product Portfolio
6.13.5 Jiujiujiu Recent Developments/Updates
6.14 Alpha
6.14.1 Alpha Corporation Information
6.14.2 Alpha Pharmaceutical Intermediates Description and Business Overview
6.14.3 Alpha Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Alpha Pharmaceutical Intermediates Product Portfolio
6.14.5 Alpha Recent Developments/Updates
6.15 Jiuzhou
6.15.1 Jiuzhou Corporation Information
6.15.2 Jiuzhou Pharmaceutical Intermediates Description and Business Overview
6.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Jiuzhou Pharmaceutical Intermediates Product Portfolio
6.15.5 Jiuzhou Recent Developments/Updates
6.16 Yongtai
6.16.1 Yongtai Corporation Information
6.16.2 Yongtai Pharmaceutical Intermediates Description and Business Overview
6.16.3 Yongtai Pharmaceutical Intermediates Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Yongtai Pharmaceutical Intermediates Product Portfolio
6.16.5 Yongtai Recent Developments/Updates
7 Pharmaceutical Intermediates Manufacturing Cost Analysis
7.1 Pharmaceutical Intermediates Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pharmaceutical Intermediates
7.4 Pharmaceutical Intermediates Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pharmaceutical Intermediates Distributors List
8.3 Pharmaceutical Intermediates Customers
9 Pharmaceutical Intermediates Market Dynamics
9.1 Pharmaceutical Intermediates Industry Trends
9.2 Pharmaceutical Intermediates Growth Drivers
9.3 Pharmaceutical Intermediates Market Challenges
9.4 Pharmaceutical Intermediates Market Restraints
10 Global Market Forecast
10.1 Pharmaceutical Intermediates Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pharmaceutical Intermediates by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Pharmaceutical Intermediates by Type (2022-2027)
10.2 Pharmaceutical Intermediates Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pharmaceutical Intermediates by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Pharmaceutical Intermediates by Application (2022-2027)
10.3 Pharmaceutical Intermediates Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pharmaceutical Intermediates by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Pharmaceutical Intermediates by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
